New patent for Allergan drug VRAYLAR

July 23, 2022 Comments Off Posted in: Patent Added

Annual Drug Patent Expirations for VRAYLAR Vraylar is a drug marketed by Allergan and is included in one NDA. It is available from two suppliers. There are three patents protecting…

The post New patent for Allergan drug VRAYLAR appeared first on DrugPatentWatch - Make Better Decisions.

Comments are closed.